Therefore, more data on the interplay between PTHrP and β2-AR in breast cancer bone metastasis are urgently required, since this knowledge could change our understanding of the dynamics of β2-AR expression in bone throughout the progression of this disease and facilitate the design of new, more effective therapeutic options. This evidence concerns the gene ADRB2 and breast cancer.